Cancer Forums and News by PhD's


News | Forums Register

Go Back   Cancer Forums and News by PhD's > Multiple Myeloma

Reply
 
Thread Tools Display Modes
  #1  
Old 11-30-2006, 02:08 PM
admin admin is offline
Administrator
 
Join Date: Nov 2006
Posts: 68
Default Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) fo

A new story entry has been added:

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with adv

Quote:
We investigated toxicity and efficacy of in vivo T-cell depletion with anti-thymocyte globulin (ATG) as part of an intensified myeloablative conditioning regimen followed by allogeneic stem cell transplantation in patients with advanced multiple myeloma. The conditioning regimen consisted of modified total body irradiation, busulfan and cyclophosphamide (n=15) or in the case of prior dose-limiting radiotherapy of busulfan and cyclophosphamide (n=3). The median age was 44 years (range, 29-53) and the median time from diagnosis to transplant was 12 months (range, 6-144). Grade II-IV acute graft-versus-host disease (GvHD) occurred in six patients (35%). Severe grade III/IV GvHD developed in one patient (6%). Three patients died of therapy-related causes (17%). A complete remission (CR) with negative immunofixation after allogeneic transplantation was seen in eight of the evaluable patients (53%). After a median follow-up of 41 months (range, 8-84), the estimated overall survival at 6 years for all patients is 77% (CI 95%: 58-96%). The estimated progression-free survival at 6 years for all patients is 31% (CI 95%: 2-59%) and 46% (CI 95%: 9-83%) for patients with CR. In vivo T-cell depletion with ATG resulted in a low rate of severe GvHD with low treatment-related mortality, and a substantial number of long-term survivors.
Reply With Quote
  #2  
Old 11-30-2006, 02:13 PM
admin admin is offline
Administrator
 
Join Date: Nov 2006
Posts: 68
Default paper

Attached you have the original journal paper detailing t cell depletion in myeloblative transplants. Some centers are doing similar work with nonmyeloablative.

translation? The person receiving this treatment woulg get 2700 grey's of radiation, enough to completely destroy their marrow, as opposed to other newer protocols wherein the patient would receive 200 or 0 grey's.

The T cell depletion causes less graft vs host disease but also is less effective towards the myeloma
Attached Files
File Type: pdf reducedintesitystemcell.pdf (134.5 KB, 1599 views)
Reply With Quote
Sponsored Links
Advertisement
Reply


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -5. The time now is 09:00 AM.